Background
==========

Canadians are experiencing an epidemic of diabetes \[[@B1],[@B2]\] that disproportionately affects First Nations people \[[@B3],[@B4]\]. Although this has serious consequences for individuals, families and the health care system largely because of chronic complications, these can be lessened with improved glycemic and lipid control \[[@B5],[@B6]\].

The Canadian Diabetes Association publishes clinical practice guidelines that include target values for glycosylated hemoglobin (A1C) and low-density lipoprotein cholesterol (LDL-C) \[[@B7]\]. We evaluated testing frequency and outcome measures of A1C and LDL-C indicators to produce population measures of quality of diabetes care and to identify sub-groups at particular risk for complications. This was achieved on a population basis through linkage of laboratory data with health care system administrative data.

Methods
=======

Study Populations
-----------------

This 2005/06 population based study of diabetes care in Saskatchewan was approved by the University of Saskatchewan, Saskatoon Health Region and Regina Qu\'Appelle Health Region Ethics Review Boards. Study populations were identified from Ministry of Health databases used to administer health care to 99% of the provincial population \[[@B8]\]. Beneficiaries were sub-divided into First Nations people (FN) and other Saskatchewan residents (OSK) by age and sex. FN are indigenous to Canada and included those registered under Section 6 of the Indian Act \[[@B9]\]. Most OSK are of European origin but include non-registered FN (\<0.5%) and Métis (about 5%) \[[@B10]\]. The provincial population was approximately one million people and \>10% were FN \[[@B11]\].

Diabetic adults aged 20 years and older were identified using a validated algorithm \[[@B12]\] based on National Diabetes Surveillance System (NDSS) case definitions \[[@B13]\]. These required one hospitalization with a discharge diagnosis of diabetes (ICD-9 250.x or ICD-10-CA E10-E14.xxx), or two physician service claims for diabetes within any 730 day period. Gestational diabetes cases were excluded. We were not able to distinguish between types 1 and 2 diabetes but \<2% of incident diabetes cases in Canada are \<20 years \[[@B14]\], the group with the highest type 1 diabetes incidence \[[@B15]\].

We define the diabetes incident year as the first fiscal year (April1 to March 31) in which an individual meets the diabetes case definition when there has been no prior diabetes diagnosis for at least two years. Thereafter, for each year that an individual is covered by Saskatchewan Health, the individual is a prevalent case. Only prevalent cases of diabetes counted on the first day (April 1) of the 2005/06 fiscal year were included in this study; they comprised the core denominators for our analyses.

Linkage of Diabetes Cases with Laboratory Data
----------------------------------------------

Using encrypted unique identifiers, prevalent cases of diabetes were linked with laboratory data from centralized laboratories in the two largest Health Regions in Saskatchewan (Saskatoon and Regina/Qu\'Appelle). This data accounted for nearly 100% of A1C tests and 50% of LDL-C tests performed in the province.

Quality of Diabetes Care Indicators
-----------------------------------

Because this study predated the 2008 clinical practice guidelines \[[@B7]\], we used an A1C target of ≤7.0% for glycemic control and an LDL-C target of \<2.5 mmol/L (now \<2.0 mmol/L) for lipid control as published in 2003 \[[@B16]\]. A1C testing was recommended at diabetes diagnosis and then 3-4 times per year; LDL-C testing was recommended at diabetes diagnosis and then every 1-3 years as clinically indicated. Finally, we chose an A1C of \>= 9.0% to indicate very poor glycemic control and a LDL-C of \>= 2.5 mmol/L as a level when use of lipid lowering drugs should be considered.

Based on the above, the quality of care indicators were: proportion of diabetes cases tested for A1C in 2005/06; of those tested, the proportion with a most recent A1C \<= 7.0%, a most recent A1C \>= 9.0% and the mean of most recent A1C tests; proportion with \>= 2 A1C tests/year; proportion with \>= 3 A1C tests/year; proportion of diabetes cases with A1C \<= 7.0% by frequency of testing (1, 2, 3, 4+ tests/year); proportion of diabetes cases ever tested for LDL-C in 2005/06; of those, the proportion with a latest LDL-C \<2.5 mmol/L, and the mean LDL-C; and proportion of OSK diabetes cases with an LDL-C \>= 2.5 mmol/L dispensed a lipid lowering drug (not available for FN). Overall results as well as by sex, ethnicity, location, age group and income quintile were calculated. Detailed descriptions of indicator derivations can be found in the Saskatchewan Health Quality Council 2008 *Quality Insight*report\'s Technical Appendix \[[@B17]\].

Analyses
--------

Most comparisons were made between groups within specific demographic sub-populations. Mean A1C and LDL-C values were compared using two tailed t-tests for two groups and one way Anova for multiple groups. For between group comparisons, we chose a reference group and calculated OR\'s with 95% confidence intervals for the remaining groups. Tests for linear trend (one sided and two sided) were used to compare within group proportions of diabetes cases with A1C \<= 7.0% by frequency of testing. Data abstraction and analyses were carried out using SAS software version 9.1.3. A p value of \<= 0.05 was considered significant.

Results
=======

Of the 50,713 prevalent diabetes cases in Saskatchewan during 2005/06 (Table [1](#T1){ref-type="table"}), 24,188 were female (47.7%) and 6,184 were FN (12.2%). A majority (53.5%) were urban dwellers and 81% were \>= 50 years. Almost half were in the lowest two income quintiles (48.3%).

###### 

Outcomes of A1C testing among Saskatchewan adults with Diabetes by Demographic Characteristics

  Characteristic    Number of persons with diabetes†   Tested for A1C   Number of persons tested   A1C \<= 7.0%   A1C \>= 9.0%   Mean A1C                                   
  ----------------- ---------------------------------- ---------------- -------------------------- -------------- -------------- ----------------- ------ ----------------- ------------
  ALL SASK          50713                              66.9                                        33920          48.3                             12.6                     7.4
  female            24188                              66.0             0.95(0.92-0.99)            15971          50.4           1.16(1.11-1.21)   12.3   0.95(0.89-1.01)   7.4^**1**^
  male\*            26525                              67.7                                        17949          46.5                             12.9                     7.5
                                                                                                                                                                            
  ETHNICITY                                                                                                                                                                 
  FN                6184                               59.0             0.72(0.68-0.76)            3646           40.6           0.80(0.74-0.86)   25.5   2.05(1.88-2.24)   8.0^**1**^
  OSK\*             44529                              68.0                                        30274          49.3                             11.1                     7.4
                                                                                                                                                                            
  LOCATION                                                                                                                                                                  
  urban\*           27147                              68.4                                        18563          49.9                             11.9                     7.4
  non-urban         23508                              65.2             0.86(0.83-0.89)            15333          46.5           0.86(0.82-0.90)   13.6   1.23(1.15-1.31)   7.5^**1**^
                                                                                                                                                                            
  AGE (years)                                                                                                                                                               
  20-29             686                                51.2             0.55(0.47-0.64)            351            40.2           0.56(0.45-0.69)   24.5   4.26(3.31-5.49)   8.1^**1**^
  30-39             2652                               54.3             0.62(0.57-0.67)            1439           37.0           0.49(0.44-0.55)   27.4   4.96(4.33-5.67)   8.1^**1**^
  40-49             6287                               62.1             0.85(0.80-0.90)            3902           42.1           0.61(0.57-0.66)   20.6   3.39(3.06-3.76)   7.8^**1**^
  50-59             10663                              69.8             1.20 (1.4-1.26)            7443           44.4           0.68(0.64-0.72)   16.6   2.58(2.36-2.83)   7.6^**1**^
  60-69             11596                              72.5             1.37(1.30-1.44)            8408           48.1           0.79(0.74-0.83)   10.6   1.54(1.40-1.70)   7.4^**1**^
  ≥70\*             18829                              65.7                                        12377          54.3                             7.1                      7.2
                                                                                                                                                                            
  INCOME QUINTILE                                                                                                                                                           
  lowest            12991                              63.1             0.76(0.72-0.81)            8195           46.0           0.81(0.75-0.86)   15.7   1.53(1.38-1.69)   7.6^**1**^
  second            11496                              66.3             0.86(0.82-0.92)            7626           47.1           0.83(0.78-0.89)   13.4   1.31(1.18-1.45)   7.5^**1**^
  third             8615                               68.8             0.96(0.90-1.02)            5923           50.3           0.94(0.88-1.01)   10.9   1.06(0.94-1.19)   7.3^**1**^
  fourth            7589                               68.8             0.95(0.89-1.02)            5220           48.2           0.87(0.81-0.94)   11.3   1.08(0.96-1.22)   7.4^**1**^
  highest\*         9436                               69.9                                        6593           51.2                             10.7                     7.3

All rates are crude rates

\*Reference category

†Includes prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06

Values in this table are based on the last A1C result reported for year

^**1**^p \< = 0.0001

Overall, 66.9% of people with diabetes had an A1C level done during 2005/06. Younger, female, non-urban people and those with lowest incomes were less likely to have an A1C test compared to their respective counterparts. However, the diabetic groups least likely to have an A1C test were those under age 40 (53.7%) and FN (59%). With the exception of females, the same demographic groups with fewest A1C tests also experienced the poorest A1C results. FN and those under age 40 exhibited the worst results with mean A1Cs of 8.0% and 8.1% respectively. The group with the best A1C profile were those aged 70+ (54.3% had A1Cs \<= 7%, 7.1% had A1Cs \>= 9% and the mean A1C was 7.2%).

Overall, 38.4% of adults with diabetes had \>= 2 and 17.5% had \>= 3 A1C tests during 2005/06 (Table [2](#T2){ref-type="table"}). Results were similar between males and females. Non-urban people were less likely than urban dwellers to have \>1 A1C tests during the year. However, those tested least frequently were FN.

###### 

Frequency of A1C testing among Saskatchewan adults with Diabetes by Demographic Characteristics

              Number of persons with diabetes\*   Persons with \>= 2 A1C tests/year   Persons with \>= 3 A1C tests/year                                   
  ----------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------- ------ ------ -----------------
  ALL SASK    48200                               18256                               38.4                                                  8436   17.5   
  female      23028                               8767                                38.1                                0.99(0.95-1.03)   4000   17.4   1.00(0.95-1.04)
  male†       25172                               9759                                38.8                                                  4436   17.6   
                                                                                                                                                          
  ETHNICITY                                                                                                                                               
  FN          5959                                1747                                29.3                                0.69(0.65-0.74)   692    11.6   0.65(0.60-0.71)
  OSK†        42241                               16779                               39.7                                                  7744   18.3   
                                                                                                                                                          
  LOCATION                                                                                                                                                
  urban†      25809                               10351                               40.1                                                  4855   18.8   
  non-urban   22338                               8160                                36.5                                0.85(0.82-0.88)   3572   16.0   0.81(0.77-0.85)

All rates are crude rates

\*Includes prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06 and who survived the year with SK Ministry of Health insurance coverage

†Reference category

Overall, the proportion of diabetic people with target A1Cs decreased from 49.1% of those tested once to 47.3% of those tested \>= 4 times (Table [3](#T3){ref-type="table"}). This downward trend was mirrored in males and OSK. Only FN experienced an improvement in target A1C by frequency of testing (38.9% of those tested once to 44.9% of those tested \>= 4 times).

###### 

Outcomes of A1C Testing by Frequency of Testing among Saskatchewan Adults with Diabetes

              Persons with only 1 A1C test/year   Persons with 2 A1C tests/year   Persons with 3 A1C tests/year   Persons with \>= 4 A1C tests/year   Test for linear trend                        
  ----------- ----------------------------------- ------------------------------- ------------------------------- ----------------------------------- ----------------------- ------ ------ ------ -----------------------------------------
  ALL SASK    15034                               49.1                            10336                           48.0                                5371                    47.5   3179   47.3   
  female      7059                                51.3                            4864                            49.8                                2581                    49.1   1467   49.7   p = 0.0259 (1 sided) = 0.0517 (2 sided)
  Male        7975                                47.1                            5472                            46.4                                2790                    46.0   1712   45.3   p = 0.0711 (1 sided) = 0.1422 (2 sided)
                                                                                                                                                                                                   
  ETHNICITY                                                                                                                                                                                        
  FN          1866                                38.9                            1073                            41.0                                453                     44.8   254    44.9   p = 0.0035 (1 sided) = 0.0070 (2 sided)
  OSK         13168                               50.5                            9263                            48.8                                4918                    47.7   2925   47.6   p = 0.0001 (1 sided) = 0.0001 (2 sided)

All rates are crude rates

\* Denominator is all prevalent diabetes cases aged 20 years and older at the beginning of fiscal year 2005-06

† Includes prevalent diabetes cases defined at beginning of fiscal year 2005/06 and who survived the year with SK Ministry of Health insurance coverage

A1C values in this table are based on the last A1C result reported for year

Table [4](#T4){ref-type="table"} shows results of LDL-C testing among adults with diabetes in Saskatchewan\'s two most populous Health Regions. Of the 24,207 prevalent diabetes cases, 11,294 were female (46.7%) and 2,321 were FN (9.6%). Most were urban (77.3%) and the majority were aged 50+ (80.3%). Almost half (48.7%) were in the lowest two income quintiles.

###### 

LDL Cholesterol Indicator outcomes among Diabetic adults in Two Saskatchewan Health regions by Demographic Characteristics

                    Number of persons with diabetes†   Tested for LDL-C   Number of persons tested   LDL-C \< 2.5 mmol/L   Mean LDL-C                           
  ----------------- ---------------------------------- ------------------ -------------------------- --------------------- ------------ ----------------- ----- -------------
  TOTAL             24207                              49.7                                          12019                 45.1                           2.7   
  female            11294                              47.6               0.89(0.85-0.94)            5379                  41.3         0.76(0.78-0.81)   2.8   p \< 0.0001
  male\*            12913                              51.4                                          6640                  48.2                           2.6   
                                                                                                                                                                
  ETHNICITY                                                                                                                                                     
  FN                2321                               29.2               0.38(0.35-0.42)            677                   47.9         1.26(1.07-1.47)   2.6   p = 0.19
  OSK\*             21886                              51.8                                          11342                 44.9                           2.7   
                                                                                                                                                                
  LOCATION                                                                                                                                                      
  urban\*           18702                              57.1                                          10679                 45.0                           2.7   
  non-urban         5476                               24.1               0.23(0.22-0.25)            1322                  46.2         1.03(0.92-1.15)   2.7   p = 0.18
                                                                                                                                                                
  AGE (years)                                                                                                                                                   
  20-29             358                                29.1               0.49(0.39-0.62)            104                   42.3         0.84(0.57-1.25)   2.8   
  30-39             1379                               35.1               0.64(0.57-0.72)            484                   39.5         0.75(0.62-0.91)   2.8   
  40-49             3040                               46.8               1.04(0.96-1.13)            1423                  42.1         0.82(0.73-0.93)   2.7   
  50-59             5268                               54.5               1.41(1.32-1.51)            2871                  43.4         0.85(0.77-0.94)   2.7   p = 0.0002
  60-69             5428                               57.9               1.62(1.51-1.74)            3144                  46.7         0.98(0.89-1.07)   2.7   
  ≥ 70\*            8734                               45.7                                          3993                  46.9                           2.7   
                                                                                                                                                                
  INCOME QUINTILE                                                                                                                                               
  lowest            6170                               45.8               0.74(0.69-0.81)            2826                  44.1         0.91(0.81-1.02)   2.7   
  second            5630                               48.4               0.81(0.74-0.88)            2726                  44.6         0.91(0.81-1.02)   2.7   
  third             4499                               49.9               0.85(0.78-0.92)            2247                  45.1         0.93(0.82-1.04)   2.7   p \< 0.02
  fourth            4044                               52.3               0.93(0.85-1.01)            2116                  45.1         0.92(0.81-1.03)   2.7   
  highest\*         3770                               54.8                                          2067                  47.4                           2.6   

All rates are crude rates

\* Reference category

† Includes prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06 in Saskatchewan\'s two largest Health Regions

Overall, 49.7% of diabetic adults had at least one LDL-C test during 2005/06. Younger, female, non-urban people and those with lowest incomes were less likely to have an LDL-C test than reference groups. However, those least likely to have an LDL-C test were younger people and FN (29.2% versus 51.8% of OSK). Females displayed among the poorest LDL-C outcomes with only 41.3% achieving target LDL-C levels compared to 48.2% of males. Mean LDL-C was also poorer for females (2.8 mmol/L) compared to males (2.6 mmol/L). In contrast to A1C findings, FN and non-urban diabetic people were more likely to achieve target LDL-C levels than their OSK and urban counterparts.

During 2005/06, 41,934 diabetic OSK lived in Saskatchewan for the entire year. Of those, 36.9% were prescribed a lipid lowering agent compared to 38.6% of 20,714 diabetic OSK living in Saskatchewan\'s two most populous Health Regions. Table [5](#T5){ref-type="table"} shows that 6,914 diabetic OSK in the two Health Regions had a most recent LDL-C level \>= 2.5 mmol/L, but only 39.2% of those received a lipid lowering drug. Although no significant differences were found by location and income quintile, there was a trend for better treatment rates with increasing income. The lowest treatment rates were observed in the oldest and youngest subjects, and among women. However, both males (27.0%) and females (18.8%) under age 40 were least likely to receive treatment.

###### 

Use of Lipid Lowering Drugs among Diabetic OSK With LDL-C \>= 2.5 MMOL/L by Demographic Characteristics

  ------------------------------------------------------------------------------------------------------------------------
                       Persons with\         Persons dispensed a lipid lowering drug   Crude rate (%)   OR (95% CI)
                       LDL-C ≥ 2.5 mmol/L†                                                              
  -------------------- --------------------- ----------------------------------------- ---------------- ------------------
  TOTAL                6914                  2711                                      39.2             

  AGE (years) Female                                                                                    

  20-39                165                   31                                        18.8             0.38 (0.26-0.58)

  40-49                389                   123                                       31.6             0.77 (0.60-0.98)

  50-59                723                   305                                       42.2             1.21 (1.00-1.46)

  60-69                795                   329                                       41.4             1.17 (0.97-1.41)

  ≥ 70\*               1157                  435                                       37.6             

                                                                                                        

  AGE (years) Male                                                                                      

  20-39                152                   41                                        27.0             0.72 (0.50-1.06)

  40-49                428                   174                                       40.7             1.34 (1.07-1.69)

  50-59                978                   442                                       45.2             1.61 (1.35-1.93)

  60-69                1003                  451                                       45.0             1.60 (1.34-1.91)

  ≥ 70\*               1124                  380                                       33.8             

                                                                                                        

  LOCATION                                                                                              

  urban\*              6196                  2416                                      39.0             

  non-urban            704                   288                                       40.9             1.09 (0.9-1.3)

                                                                                                        

  INCOME QUINTILE                                                                                       

  lowest               1544                  569                                       36.9             0.92 (0.79-1.08)

  second               1566                  606                                       38.7             0.97 (0.83-1.13)

  third                1320                  515                                       39.0             0.96 (0.82-1.13)

  fourth               1267                  525                                       41.4             1.05 (0.90-1.24)

  highest\*            1191                  482                                       40.5             
  ------------------------------------------------------------------------------------------------------------------------

\*Reference category

Drug prescribing data was not available for FN, hence, analysis for lipid lowering prescribing indicators was limited to OSK

Data are stratified by sex because age-sex interaction was present

† Sub-group of prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06 in Saskatchewan\'s two largest Health Regions

Discussion
==========

We measured A1C and LDL-C quality of care indicators in Saskatchewan\'s diabetic population by linking health care system administrative data with laboratory data. While over 2/3 of people with diabetes received A1C testing, less than 50% achieved target levels and 12.6% exhibited very poor glycemic control. Almost 50% of the study population received LDL-C testing but only 45.1% of those achieved target levels and only 39.2% of those with values above the target of 2.5 mmol/L were prescribed a lipid lowering drug.

Diabetic adults who were female, FN, non-urban, younger or in lower income quintiles were less likely to receive A1C and LDL-C testing. Apart from females, the same groups also experienced poorer glycemic control. While younger subjects and those with lower incomes also displayed poorer LDL-C results, the largest disparity was observed between sexes. Females had higher mean LDL-C concentrations and were less likely to achieve target LDL-C levels. Despite that, diabetic OSK females with sub-optimal LDL-C were the group least likely to receive a lipid lowering agent. This was particularly evident in younger women, so likely included individuals with type 1 diabetes. A somewhat unexpected finding was that FN exhibited better LDL-C profiles than OSK. In the context of overall evidence for poorer quality of diabetes care, this observation suggests that there may be underlying differences in lipid metabolism between FN and OSK \[[@B18]\].

The proportion of diabetic people achieving target A1C levels decreased with frequency of testing among OSK but increased among FN. The reasons behind the former finding are complex but possibly explained in part by more frequent follow-up care in those with more brittle or complicated diabetes histories. In contrast, the small numbers of FN with more frequent A1C testing likely represented a subgroup with better diabetes care. This suggests that the overall poorer glycemic control experienced by FN may be subject to improvement through closer monitoring.

Although some of the statistically significant differences found here (particularly for mean A1C and LDL-C) may not be clinically problematic, it is important to highlight that the poorest overall results with respect to frequency of testing and achievement of target values, occurred among diabetic FN people and were substantive. While not unexpected, these findings provide evidence for ethnic-based disparities in quality of diabetes care. This is reflected in higher rates of many diabetes complications including amputations, strokes and end stage renal disease, as well as in higher mortality rates among FN as we have recently shown using the same methodology \[[@B19]\]. Although the reasons behind these disparities are perplexing in the context of a universal health care system, a recent national survey of diabetes care in FN communities shows promise in elucidating at least some of the underlying problems by examining individual level factors \[[@B20]\]. Furthermore, these sobering findings and their causes are highly relevant to other indigenous and developing populations who are also experiencing disproportionate rates of diabetes and diabetes complications \[[@B21]\].

Strengths of this study include employment of a validated algorithm to identify diabetes cases \[[@B12]\], inclusion of total Saskatchewan populations, ability to carry out a linkage between laboratory and health care system administrative data, and the ability to sub-divide the population by ethnicity. A significant limitation in the use of secondary data to conduct diabetes research is the unavailability of important individual level health determinants such as smoking, hypertension, and obesity as well as the inability to determine the impact of acculturation on First Nations people. Other limitations included an inability to identify people of Aboriginal heritage other than FN, but this reduces the true differences between FN and OSK. Second, identifying cases using administrative data may underestimate the incidence and prevalence of diabetes \[[@B12]\]. Third, although we could not differentiate between types 1 and 2 diabetes, most Canadian adults with diabetes have T2DM \[[@B14]\]; the proportion is even higher for FN \[[@B15]\]. Nonetheless, it is likely that the A1C and LDL-C indicator results for younger people with diabetes are partly attributable to OSK with type 1 diabetes. Finally, there may be overlap between the demographic groups that we have described. In particular, poorer results for FN in A1C indicators may be partly related to younger age and lower incomes (or vice versa). However, that would not explain the poor results among young OSK (particularly females) regarding treatment with lipid lowering agents.

Conclusions
===========

Linkage of laboratory data with health care system administrative data can be used to provide standardized information for people with diabetes on a population basis that can be used to identify deficiencies in care and support quality improvement initiatives. The potential to do so exists throughout Canada and other jurisdictions with universal health care systems and/or electronic medical records serving large patient groups. For example, a recent study described the utilization and outcomes of A1C testing among people with diabetes in eastern Ontario \[[@B22]\]. Although their results were consistent with those reported here, they did not provide information for FN.

We have now shown that less than 50% of diabetes cases in Saskatchewan achieved optimal glycemic and lipid control and even smaller proportions were tested as frequently as recommended. Furthermore, disparities were most evident among FN who exhibited substantially lower testing rates and poorer glycemic control than others. The fact that significant gaps exist between evidence-based guidelines for diabetes care and their implementation is a cause for concern. These findings should provide an impetus for understanding those gaps, and for developing and monitoring new strategies designed to improve the quality of diabetes care.
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